Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fadhela Bouafia
Observed names:
F Bouafia,
F. Bouafia
Institutions:
Hospices Civils de Lyon,
Hôpital Lyon Sud
Observed institutions:
Lyon 1 Université,
Centre Hospitalier Universitaire de Lille,
Hospices Civils de Lyon,
Hôpital Lyon Sud,
Hôpital Edouard Herriot
ORCID:
0000-0001-7115-6895
Observed ORCID:
0000-0001-7115-6895
OpenAlex ID:
A5076308348
Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed
2000
·
Catherine Thieblemont
, Françoise Berger
, et al.
·
Blood
·
513
Subclinical Late Cardiomyopathy After Doxorubicin Therapy for Lymphoma in Adults
2004
·
O. Hequet
, Q.H. Le
, et al.
·
Journal of Clinical Oncology
·
338
Mantle cell lymphoma: a retrospective study of 121 cases
1998
·
H Samaha
, C Dumontet
, et al.
·
Leukemia
·
206
High CD34+ Cell Counts Decrease Hematologic Toxicity of Autologous Peripheral Blood Progenitor Cell Transplantation
1998
·
Nicolas Ketterer
, Gilles Salles
, et al.
·
Blood
·
186
Commercial anti‐CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center
2020
·
Pierre Sesques
, Emmanuelle Ferrant
, et al.
·
American Journal of Hematology
·
138
PDF
Gemcitabine as a single agent in the treatment of relapsed or refractory low‐grade non‐Hodgkin's lymphoma
2001
·
C. Dumontet
, F. Morschhauser
, et al.
·
British Journal of Haematology
·
100
Frequency and significance of anemia in non-Hodgkin’s lymphoma patients
1998
·
I. Moullet
, G. Salles
, et al.
·
Annals of Oncology
·
98
Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphoma
2004
·
B Lemieux
, S Tartas
, et al.
·
Bone Marrow Transplantation
·
91
Prognostic Impact of 18F-FDG PET/CT in Patients With Aggressive B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T Cells
2021
·
Pierre Sesques
, Jérémie Tordo
, et al.
·
Clinical Nuclear Medicine
·
73
Clinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specified
2021
·
Estelle Bourbon
, Delphine Maucort-Boulch
, et al.
·
Blood Advances
·
70
Intensive therapy with peripheral stem cell transplantation in 16 patients with mantle cell lymphoma
1997
·
N. Ketterer
, G. Salles
, et al.
·
Annals of Oncology
·
62
Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma
2002
·
C Thieblemont
, C Dumontet
, et al.
·
Bone Marrow Transplantation
·
46
Infections following peripheral blood progenitor cell transplantation for lymphoproliferative malignancies: etiology and potential risk factors
1999
·
Nicolas Ketterer
, Daniel Espinouse
, et al.
·
The American Journal of Medicine
·
44
Autoimmune thrombocytopenic purpura after autologous stem cell transplantation
2003
·
O Hequet
, G Salles
, et al.
·
Bone Marrow Transplantation
·
42
Outcome in Relation to Treatment Modalities in 48 Patients with Localized Gastric MALT Lymphoma: A Retrospective Study of Patients Treated During 1976-2001
2002
·
Catherine Thieblemont
, Charles Dumontet
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
33
Profiles and prognostic values of LDH isoenzymes in patients with non-Hodgkin’s lymphoma
1999
·
C Dumontet
, J Drai
, et al.
·
Leukemia
·
32
Maintenance Therapy with a Monthly Injection of Alemtuzumab Prolongs Response Duration in Patients with Refractory B-cell Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (B-CLL/SLL)
2003
·
Catherine Thieblemont
, Fadhela Bouafia
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
31
Epileptic seizures after autologous peripheral blood progenitor infusion in a patient treated with high-dose chemotherapy for myeloma
2002
·
O Hequet
, C Dumontet
, et al.
·
Bone Marrow Transplantation
·
28
HLA-DR expression on monocytes and outcome of anti-CD19 CAR T-cell therapy for large B-cell lymphoma
2022
·
Estelle Bourbon
, Pierre Sesques
, et al.
·
Blood Advances
·
24
PDF
Second treatment with rituximab in B-cell non-Hodgkin's lymphoma: efficacy and toxicity on 41 patients treated at CHU-Lyon Sud
2004
·
Bernard Lemieux
, Fadhela Bouafia
, et al.
·
The Hematology Journal
·
24
Multifocal progressive leukoencephalopathy occurring after refractory anemia and multiple infectious disorders consecutive to severe lymphopenia
2002
·
O. Hequet
, G. Salles
, et al.
·
Annals of Hematology
·
16
Skin Lesions in Malignancy
2001
·
P. Steve
, C. Thieblemont
, et al.
·
Journal of Clinical Oncology
·
16
Toxicities after peripheral blood progenitor cell transplantation for lymphoid malignancies: analysis of 300 cases in a single institution
1999
·
N Ketterer
, A Sonet
, et al.
·
Bone Marrow Transplantation
·
14
Clinical and pharmacokinetic phase II study of fotemustine in refractory and relapsing multiple myeloma patients
2003
·
C. Dumontet
, J. Jaubert
, et al.
·
Annals of Oncology
·
9
PDF
A prospective study of intensive induction therapy with high-dose consolidation in patients with aggressive non-Hodgkin's lymphoma and two or three adverse prognostic factors
2000
·
C Dumontet
, C Thieblemont
, et al.
·
Leukemia
·
7
Show more works
View as search
Works count:
30
Citation count:
2,248
H-index:
20
I10-index:
23
Year
Topic
Type